About this document
RTOG 0924 Prostate Cancer Trial Overview by mark is a document available to read on EtoBox.
This document describes the RTOG 0924 clinical trial, which will evaluate androgen deprivation therapy and high dose radiotherapy with or without whole-pelvic radiotherapy for unfavorable intermediate or favorable high risk prostate cancer. The trial is led by NRG Oncology and involves researchers from multiple networks. It provides contact information for the study team, describes the agents being studied, lists participating sites, and provides instructions for submitting documents and data to regulatory
- Author
- mark
- Language
- EN